Rama Dajani

Rama Dajani

Auto-generated profile, based on publicly available information

Rama Dajani

Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2023 in Nature
Verified
Journal Article
Closed access
PDF file
RSRalf Schmidt
Ralf Schmidt
CWCarl C. Ward
Carl C. Ward
RDRama Dajani
Rama Dajani
ZAZev Armour-Garb
Zev Armour-Garb
MOMineto Ota
Mineto Ota
AMAlex Marson
Alex Marson

29 April 2026 in medRxiv
Verified
Preprint
Open access
PDF file
YRYvonne Rong
Yvonne Rong
MVMikhail Vysotskiy
Mikhail Vysotskiy
PCPeixin Amy Chen
Peixin Amy Chen
EAEkansh Agrawal
Ekansh Agrawal
EMEdward Marsh
Edward Marsh
DNDavid N. Nguyen
David N. Nguyen
Distinguishing pathogenic from benign mutation is critical for genetic diagnosis. A CRISPR-targeted saturation genome editing (SGE) platform in primary human cells assessed 489 single nucleotide variants (SNVs) in exon 5 of IL2RG, the gene causing X-linked SCID. The functional impact was clearly defined for 470 variants, agreeing with 100% (18/18) of ClinVar-deposited benign or likely benign annotations, and 100% (42/42) of pathogenic or likely pathogenic annotations. We discovered 90 novel loss-of-function mutations and validated an expected block in T-lymphocyte differentiation from edited hematopoietic stem cells.